DocPlanner inks $20 mln Series C, also merges with rival Doctoralia

European medical booking platform DocPlanner has secured $20 million in Series C funding. Target Global led the round with participation from ENERN Investments and EBRD. Also, DocPlanner has merged with Spain-based rival Doctoralia. No financial terms were disclosed.

7 June 2016•5 mins read
Feature image
LinkedInXEmail
LinkedInXEmail